DarioHealth Corp. (NASDAQ:DRIO – Get Free Report) crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $1.53 and traded as low as $0.81. DarioHealth shares last traded at $0.83, with a volume of 333,260 shares traded.
DarioHealth Stock Down 5.3 %
The company has a 50-day simple moving average of $1.18 and a 200-day simple moving average of $1.52. The company has a debt-to-equity ratio of 0.31, a current ratio of 2.95 and a quick ratio of 2.67. The firm has a market cap of $23.65 million, a PE ratio of -0.47 and a beta of 1.53.
DarioHealth (NASDAQ:DRIO – Get Free Report) last released its earnings results on Thursday, August 8th. The company reported ($0.08) earnings per share for the quarter, topping the consensus estimate of ($0.51) by $0.43. The business had revenue of $6.26 million during the quarter, compared to the consensus estimate of $7.57 million. DarioHealth had a negative return on equity of 76.11% and a negative net margin of 282.38%. Analysts expect that DarioHealth Corp. will post -1.53 earnings per share for the current fiscal year.
Institutional Trading of DarioHealth
About DarioHealth
DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
Further Reading
- Five stocks we like better than DarioHealth
- Upcoming IPO Stock Lockup Period, Explained
- Cassava Sciences: A Hot Stock to Trade, Invest, or Avoid?
- What to Know About Investing in Penny Stocks
- MarketBeat Week in Review – 8/5 – 8/9
- How Investors Can Find the Best Cheap Dividend Stocks
- The Cannabis Sector: Profitability Takes Center Stage
Receive News & Ratings for DarioHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DarioHealth and related companies with MarketBeat.com's FREE daily email newsletter.